Merit Medical Systems (NASDAQ: MMSI) COO exercises options and sells 5,000 shares

Rhea-AI Filing Summary

Merit Medical Systems' chief operating officer Neil W. Peterson reported an option exercise and share sale in company stock. On January 6, 2026, he exercised 5,000 non-qualified stock options with an exercise price of $54.4 per share, receiving 5,000 shares of common stock. The same day, he sold 5,000 common shares at a price of $90 per share, leaving him with 28,369 common shares held directly afterward. The filing also shows remaining non-qualified stock options for 25,000 shares at an exercise price of $68.33 and 13,576 shares at $70.58, all held directly. The option exercise and related sale were carried out under a Rule 10b5-1 trading plan adopted on November 6, 2024.

Insights

Insider transactions analyst

COO exercises options and sells 5,000 shares under a pre-set 10b5-1 plan.

The chief operating officer of Merit Medical Systems, Neil W. Peterson, exercised 5,000 non-qualified stock options at an exercise price of $54.4 per share, converting them into common stock. He then sold 5,000 common shares at $90 per share on January 6, 2026, leaving a reported balance of 28,369 directly held common shares.

The filing notes that these transactions were executed pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2024, indicating they were pre-arranged rather than discretionary on the trade date. After the exercise, the options with a $54.4 exercise price were exhausted, while options for 25,000 shares at $68.33 and 13,576 shares at $70.58 remain outstanding. The information describes planned portfolio management activity rather than a disclosed change in company fundamentals.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Peterson Neil W.

(Last) (First) (Middle)

1600 W MERIT PARKWAY

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MERIT MEDICAL SYSTEMS INC [ MMSI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF OPERATING OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
01/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, No Par Value	01/06/2026		M(1)		5,000	A	$54.4	33,369	D
Common Stock, No Par Value	01/06/2026		S(1)		5,000	D	$90	28,369	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified stock options (right to buy)	$54.4	01/06/2026		M(1)			5,000	04/25/2020(2)	04/25/2026	Common Stock	5,000	$0	0	D
Non-qualified stock options (right to buy)	$68.33							08/19/2022(3)	08/19/2028	Common Stock	25,000		25,000	D
Non-qualified stock options (right to buy)	$70.58							02/28/2024(4)	02/28/2030	Common Stock	13,576		13,576	D

Explanation of Responses:

1. The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2024.

2. Becomes exercisable in equal annual installments of 20% commencing 04/25/2020.

3. Becomes exercisable in equal annual installments of 25% commencing 08/19/2022.

4. Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.

	/s/ Brian G. Lloyd, Attorney-in-Fact	01/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider in this Merit Medical Systems (MMSI) Form 4 filing?

The insider is Neil W. Peterson, who serves as chief operating officer of Merit Medical Systems.

What transactions did the Merit Medical Systems (MMSI) COO report on January 6, 2026?

On January 6, 2026, the COO exercised 5,000 non-qualified stock options at $54.4 per share and sold 5,000 common shares at $90 per share.

How many Merit Medical Systems (MMSI) shares does the COO hold after these transactions?

After the reported transactions, the COO directly holds 28,369 shares of Merit Medical Systems common stock.

Were the COO’s Merit Medical Systems (MMSI) trades made under a Rule 10b5-1 plan?

Yes. The filing states the option exercise and sales were effected under a Rule 10b5-1 trading plan adopted on November 6, 2024.

What stock options in Merit Medical Systems (MMSI) remain outstanding for the COO?

Outstanding non-qualified stock options include 25,000 shares at an exercise price of $68.33 and 13,576 shares at $70.58, all relating to common stock.

What do the vesting footnotes in the Merit Medical Systems (MMSI) Form 4 indicate?

The footnotes explain that the option grants become exercisable in annual installments of either 20% or 25% starting on specific commencement dates listed in the filing.